Contributors

From the Editors

Drug Pipeline
Drugs to Watch: Anticipated Q4 2023 Launches
The drug pipeline continues to flow. See what new therapies are expected to launch in the fourth quarter of 2023. More
Briefing
Drug Pipeline
Increasing Provider Understanding of Biosimilars with Proactive Outreach
Increasing Provider Understanding of Biosimilars with Proactive Outreach More
Briefing
Cost Management
A Balanced Approach to Weight Management Drugs
Strategies for balancing coverage and spend for high-cost diabetes and obesity medications More
Briefing
Cost Management
Q2 2023 Gene Therapy Report: Promising New Treatments on the Horizon
An update on the gene therapy pipeline More
Briefing
Specialty
7 Stats That Show What Providers Think About Biosimilars
7 stats that show what providers think about biosimilars More
Briefing
Specialty
Advancing Our Clinical Agenda
Advancing Caremark’s clinical agenda through population health More
Commentary
Cost Management
The Dynamic PBM Landscape
The changing PBM landscape holds challenges for payors More
Commentary
Specialty
Member Experience: A Specialty Patient’s Journey
Member Experience: A Specialty Patient’s Journey More
Briefing